Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate

We are Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate CAS:89-33-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate
CAS.NO:89-33-8
Synonyms:3-Ethoxycarbonyl-1-phenyl-2-pyrazolin-5-one;PCEP (CarbethoxyPyrazolone);ethyl 1-phenylpyrazol-5-one-3-carboxylate;1-Phenyl-3-carboethoxy-5-pyrazolone;CEP
Molecular Formula:C12H12N2O3
Molecular Weight: 232.23500
 
Physical and Chemical Properties:
Density:1.25 g/cm3
Boiling point:335.3ºC at 760 mmHg
Melting point:252ºC (Decomposes)
Flash point:156.6ºC
Index of Refraction:1.594
 
Specification:
Appearance:Light yellow crystalline powder
Purity:≥99.0%
 
Packing: 25kg drum
Storage:This product should be sealed in a cool dry place.
Application:Mainly used for the organic synthesis of C.I. Pigment Red 38; 39; 42 varieties of coupling components.

Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate


Related News: “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.1-Bromo-2-iodobenzene The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.2-etilhexil 4- (dimetilamino) benzoato CAS:21245-02-3 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.1228-53-1 Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.

Related Products
Product Name
Isobornyl acrylate View Details
2-Methoxy-4-methylpyridine View Details
Methyl 2-Amino-4-Bromobenzoate View Details
1,8-Diazafluoren-9-one manufacturer (R)-(-)-Glycidyl phthalimide manufacturer Fmoc-4-Chloro-D-Phe-OH manufacturer [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] acetate manufacturer N-(1,3-Dihydro-1,3-dioxoisobenzofuran-4-yl)acetamide manufacturer